Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene therapy
Biotech
J&J gene therapy fails ph. 3 rare eye disease trial
The treatment failed to improve the vision-guided mobility of patients with the eye disease X-linked retinitis pigmentosa.
Darren Incorvaia
May 5, 2025 11:33am
Vertex discontinues AAV research for gene therapies
May 2, 2025 6:22pm
Lexeo locks in pivotal trial plan as gene therapy data accrue
Apr 7, 2025 9:37am
Gene therapy biotech secures $150M for eye disease candidates
Apr 2, 2025 7:30am
Beam gene therapy passes early safety test in AATD
Mar 10, 2025 12:22pm
Regeneron gene therapy restores hearing in 10 of 11 children
Feb 24, 2025 3:00pm
